Supply Exclusive Medicines With Active Ingredients Nivolumab, Ipilimumab, Abatacept, Fedratinib, Mavacamten, Deucravacitinib And Azacitidine In Tablets

Name: Supply Exclusive Medicines With Active Ingredients Nivolumab, Ipilimumab, Abatacept, Fedratinib, Mavacamten, Deucravacitinib And Azacitidine In Tablets
Start: 2025-08-09
End: -0001-11-30
Location: Servicio Murciano de Salud - Junta de Compras

Servicio Murciano de Salud - Junta de Compras Spain has Released a tender for Supply Exclusive Medicines With Active Ingredients Nivolumab, Ipilimumab, Abatacept, Fedratinib, Mavacamten, Deucravacitinib And Azacitidine In Tablets in Pharmaceuticals. The tender was released on Aug 08, 2025.

Country - Spain

Summary - Supply Exclusive Medicines With Active Ingredients Nivolumab, Ipilimumab, Abatacept, Fedratinib, Mavacamten, Deucravacitinib And Azacitidine In Tablets

Deadline - login to view

GT reference number - 115232351

Product classification - Immunosuppressive agents

Organization Details:

Address - Spain

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 115232351

Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Supply exclusive medicines with active ingredients nivolumab, iPilimumab, abatacept, fedratinib, mavacamten, deucravacitinib and azacitidine in tabletslocal title:: Suministro Medicamentos exclusivos con principios activos nivolumab, ipi limumab, abatacept, fedratinib, mavacamten, deucravacitinib y azacitidina en comprimidosContract Duration: : 24 MONTHContract Type: : Supplylocal description: : Suministro Medicamentos exclusivos con principios activos nivolumab, ipilimumab, abatacept, fedratinib, mavacamten, deucravacitinib y azacitidina en comprimidosNet Budget Euro: : 20825437.5Net Budget LC: : 20825437.5 dispatch_date: 2025-08-06 00:00:00 est_amount: 20825437.5 lot_details: 1

Gt Ref Id - 115232351

Deadline - Nov 30, -0001